Translational Research allows the development of personalized treatment for cancer

12 - 10 - 2009

Today, we know much more about why a cell becomes cancerous and about which proteins and genes are responsible for this happening

LIF, a gene involved in the proliferation of tumour stem cells

4 - 6 - 2009

The Vall d’Hebron Institute of Oncology (VHIO) has published a new study describing a new molecular mechanism that regulates the renewal of the glioma stem cells. The findings represent an important advancement in the research centred on one of the most aggressive brain tumours, the glioblastoma multiforme

Therapeutic targets in pancreatic cancer

3 - 18 - 2009

Davide Melisi will offer a conference about TGF-ß signaling for anticancer therapies

mTOR, cell functions regulator

2 - 15 - 2009

Christopher Proud, from Southampton University, presents the latest advancements related to mTOR, involved in certain cancers

Advancements in resistance to Tamoxifen

2 - 13 - 2009

Antonio Hurtado, from the Cambridge Research Institute, will offer a seminar on the factors that cause resistance to Tamoxifen on breast cancer patients

The Translational Biomedicine and Oncology Research Consortium has been created

1 - 12 - 2009

It is the first National Agreement that includes the Academic environment, basic research, clinical research and the pharmaceutical industry

Grant for the research in colorectal cancer

11 - 28 - 2008

The "Olga Torres" Foundation awards to a VHIO research group a grant for the research on tumor stem cells

Therapeutic targets for cancer

11 - 7 - 2008

Arkaitz Carracedo, from the Harvard Medical School, gives a lecture on the latest developments on potential therapy for cancer

José Baselga is awarded the prize Jaime I in Medical Research in Alicante

10 - 10 - 2008

According to the Director of VHIO, "the race in research against cancer has only just begun"